Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
2nd Department of General Surgery, Jagiellonian University, Krakow, Poland; Centre for Research, Training and Innovation in Surgery (CERTAIN Surgery), Krakow, Poland.
Surg Obes Relat Dis. 2018 Nov;14(11):1766-1782. doi: 10.1016/j.soard.2018.08.003. Epub 2018 Aug 12.
Excess visceral adipose tissue has been identified as an important risk factor for obesity-related co-morbidities. Conflicting information exists on whether omentectomy added to bariatric surgery is beneficial to metabolic variables.
To evaluate the impact of omentectomy added to bariatric surgery on metabolic outcomes SETTING: University Hospital, Canada.
MEDLINE, EMBASE, and PubMed were searched up to May 2018. Studies were eligible for inclusion if they were randomized controlled trials comparing omentectomy added to bariatric surgery with bariatric surgery alone. Primary outcome measures were absolute change in metabolic variables (body mass index, insulin, glucose, cholesterol, lipoproteins, and triglycerides); secondary outcomes were changes in adipocytokines. Pooled mean differences (mean deviation; MD) were calculated using random effects meta-analyses, and heterogeneity was quantified using the I statistic.
Ten trials involving a total of 366 patients met the inclusion criteria with a median follow-up time of 1 year after surgery. Adding omentectomy to bariatric surgery demonstrated a minimal but statistically significant decrease in body mass index compared with bariatric surgery alone (MD 1.29, 95% confidence interval .35-2.23, P = .007, I = 0%, 10 trials). Conversely, patients who underwent bariatric surgery alone had significant increases in high-density lipoprotein (MD -2.12, 95% confidence interval -4.13 to -.11, P = .04, I = 0%, 6 trials). Other metabolic outcomes and adipocytokines showed no significant difference between procedures.
The addition of omentectomy to bariatric surgery results in minimal reduction of body mass index. Considering no overall improvement in metabolic outcomes and the time and effort required, the therapeutic use of omentectomy added to bariatric surgery is not warranted.
过多的内脏脂肪组织已被确定为肥胖相关合并症的一个重要危险因素。关于网膜切除术是否有益于减肥手术的代谢变量,存在相互矛盾的信息。
评估网膜切除术在减肥手术中的应用对代谢结果的影响。
加拿大大学医院。
检索 MEDLINE、EMBASE 和 PubMed,截止日期为 2018 年 5 月。纳入的研究为比较网膜切除术联合减肥手术与单纯减肥手术的随机对照试验。主要观察指标为代谢变量(体重指数、胰岛素、血糖、胆固醇、脂蛋白和甘油三酯)的绝对变化;次要观察指标为脂肪细胞因子的变化。采用随机效应荟萃分析计算汇总平均差异(均数差值;MD),并用 I ²统计量量化异质性。
10 项试验共纳入 366 例患者,手术 1 年后的中位随访时间为 1 年。与单纯减肥手术相比,网膜切除术联合减肥手术可使体重指数降低,但差异无统计学意义(MD 1.29,95%置信区间.35-2.23,P=0.007,I²=0%,10 项试验)。相反,单纯减肥手术患者的高密度脂蛋白显著增加(MD-2.12,95%置信区间-4.13 至-.11,P=0.04,I²=0%,6 项试验)。其他代谢结果和脂肪细胞因子在两种手术方式之间无显著差异。
减肥手术中添加网膜切除术可使体重指数轻微下降。考虑到代谢结果无总体改善,且需要耗费时间和精力,因此减肥手术中添加网膜切除术的治疗应用并不合理。